Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

2.0K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.0K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

628
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
628
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

779
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
779
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.6K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K
Peptic Ulcer01:27

Peptic Ulcer

27
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
27
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

1.1K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Alimentary pharmacology & therapeutics·2026
Same author

Management of Refractory Helicobacter pylori Infection.

Gastro hep advances·2026
Same author

DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) Is More: A Rare Case of Acalculous Cholecystitis.

ACG case reports journal·2025
Same author

Upper endoscopy in Solomon Islands: A four-year retrospective study.

Science progress·2025
Same author

<i>Helicobacter pylori</i> antibiotic resistance: a global challenge in search of solutions.

Gut·2025
Same author

High Economic Burden Yet Low Clinical Value: Why Is so Much Sucralfate Prescribed?

Basic & clinical pharmacology & toxicology·2025
Same journal

Sarcopenia in Patients With MASLD/MASH.

Gastroenterology & hepatology·2026
Same journal

The Evolving Concept of a Therapeutic Window of Opportunity for Crohn's Disease.

Gastroenterology & hepatology·2026
Same journal

Inflammatory Bowel Disease and Eosinophilic Esophagitis.

Gastroenterology & hepatology·2026
Same journal

Redefining Early Intervention and the Window of Opportunity in Crohn's Disease.

Gastroenterology & hepatology·2026
Same journal

Management of Perforation During Polypectomy.

Gastroenterology & hepatology·2026
Same journal

Meditative Movement Approaches for Irritable Bowel Syndrome.

Gastroenterology & hepatology·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

888

Practice Tips From the Updated Helicobacter pylori Treatment Guidelines.

Martin Ventoso1, Steven F Moss1

  • 1Division of Gastroenterology, Department of Medicine, The Warren Alpert Medical School of Brown University, Rhode Island Hospital/BrownHealth & Providence VA Medical Center, Providence, Rhode Island.

Gastroenterology & Hepatology
|March 26, 2026
PubMed
Summary
This summary is machine-generated.

The 2024 American College of Gastroenterology guidelines update Helicobacter pylori management with new first-line treatments and address rising antimicrobial resistance. Key changes include updated screening, treatment selection, and susceptibility testing recommendations.

Keywords:
Helicobacter pyloriantimicrobial stewardshipgastric cancer preventionguidelinesscreeningtreatment

More Related Videos

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.6K
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

434

Related Experiment Videos

Last Updated: Mar 27, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

888
Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
06:40

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection

Published on: July 28, 2023

4.6K
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

434

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Clinical Practice Guidelines

Background:

  • The American College of Gastroenterology (ACG) has released updated guidelines for managing Helicobacter pylori (H pylori) infection in 2024.
  • These new guidelines replace the 2017 recommendations, incorporating significant advancements in treatment and understanding of antimicrobial resistance.
  • Antimicrobial resistance to common H pylori treatments like clarithromycin, levofloxacin, and metronidazole now exceeds 30%.

Purpose of the Study:

  • To summarize the key clinical updates in the 2024 ACG H pylori management guidelines.
  • To highlight the differences between the 2024 and previous 2017 guidelines.
  • To provide a digestible overview for gastroenterologists and clinicians treating H pylori infections.

Main Methods:

  • Review and synthesis of the 2024 American College of Gastroenterology guidelines for H pylori infection.
  • Comparison of the updated recommendations with the previous 2017 guidelines.
  • Focus on changes in screening, first-line treatment selection, and antimicrobial susceptibility testing.

Main Results:

  • The 2024 guidelines introduce new recommendations for H pylori screening practices.
  • Updated guidance is provided on selecting optimal first-line treatment regimens, considering newly approved options.
  • Emphasis is placed on the use of antimicrobial susceptibility testing for refractory H pylori infections.

Conclusions:

  • The 2024 ACG guidelines represent a significant update in H pylori management, reflecting new treatment options and rising resistance.
  • Clinicians should familiarize themselves with these changes to optimize patient care and treatment outcomes.
  • The updated guidelines aim to improve the efficacy of H pylori eradication strategies in clinical practice.